Results 261 to 270 of about 117,810 (327)

Associations Between Prepregnancy Menstrual Characteristics, Age at Menarche, and the Risk of Gestational Diabetes Mellitus: A Matched Case–Control Study

open access: yesJournal of Diabetes Research, Volume 2026, Issue 1, 2026.
Background Inconsistencies exist in the literature regarding the associations among age at menarche (AAM), prepregnancy menstrual characteristics, and the risk of gestational diabetes mellitus (GDM). These discrepancies may be attributable to variations in population demographics.
Yushuang Su   +8 more
wiley   +1 more source

FT3 Levels and Systemic Inflammation: Evidence From a Population‐Based NHANES Analysis

open access: yesMediators of Inflammation, Volume 2026, Issue 1, 2026.
Objective Previous studies suggest a complex interaction between 3,3′,5‐triiodo‐L‐thyronine (T3) and inflammation, but this relationship remains unclear. This study investigates the association between free triiodothyronine (FT3) levels and inflammatory markers in the US population using National Health and Nutrition Examination Survey (NHANES) data ...
Liu Yang   +7 more
wiley   +1 more source

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Although poly(adenosine diphosphate‐ribose) polymerase inhibitors (PARPis) and bevacizumab were approved as first‐line maintenance for advanced ovarian cancer (OC), evidence comparing this combination with PARPi monotherapy, especially in BRCA‐mutated/homologous recombination‐deficient (HRD) patients, is lacking.
Lingying Wu   +56 more
wiley   +1 more source

Genetic Variations in Vitamin D Metabolism Linking Epigenetic Regulation and Microbiota Interactions: From Phenotype to Genotype. [PDF]

open access: yesCureus
Meral G   +8 more
europepmc   +1 more source

SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata

open access: yes
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 1, Page e5-e7, January 2026.
Ziad Reguiai   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy